By the time we have approval and mTNBC final data, should be above $2. At that point we can uplist. With uplisting we should go to $4 - $5 within a couple of months. If FDA accepts BLA submission on mTNBC $6 - $7.

All based on no more than 60 million shares further dilution. Which should be possible with a slight discount to the share price and no warrants or using other financing options.

I will be waiting for all those who said they'd sell out at $5 or less to actually sell out.